Your search returned 10 results.

Results
	1.	Some statistical methods for multiple endpoints in clinical trials. [electronic resource] by Zhang, J Quan, H Ng, J Stepanavage, M E Producer: 19970818 In: Controlled clinical trials vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia. [electronic resource] by Stein, E Plotkin, D Bays, H Davidson, M Dujovne, C Korenman, S Stepanavage, M Mercuri, M Producer: 20000928 In: The American journal of cardiology vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist. [electronic resource] by Sciberras, D G Polvino, W J Gertz, B J Cheng, H Stepanavage, M Wittreich, J Olah, T Edwards, M Mant, T Producer: 19970529 In: British journal of clinical pharmacology vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease. [electronic resource] by Bachmann, K Sullivan, T J Reese, J H Jauregui, L Miller, K Scott, M Yeh, K C Stepanavage, M King, J D Schwartz, J Producer: 19950929 In: Journal of clinical pharmacology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. [electronic resource] by Rogers, J D Zhao, J Liu, L Amin, R D Gagliano, K D Porras, A G Blum, R A Wilson, M F Stepanavage, M Vega, J M Producer: 19991110 In: Clinical pharmacology and therapeutics vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia. [electronic resource] by Nussbaum, S R Warrell, R P Rude, R Glusman, J Bilezikian, J P Stewart, A F Stepanavage, M Sacco, J F Averbuch, S D Gertz, B J Producer: 19930826 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers. [electronic resource] by Lee, Y Conroy, J A Stepanavage, M E Mendel, C M Somers, G McLoughlin, D A Olah, T V De Smet, M Keymeulen, B Rogers, J D Producer: 19990610 In: British journal of clinical pharmacology vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group. [electronic resource] by Stein, E A Davidson, M H Dobs, A S Schrott, H Dujovne, C A Bays, H Weiss, S R Melino, M R Stepanavage, M E Mitchel, Y B Producer: 19980901 In: The American journal of cardiology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. [electronic resource] by Ose, L Davidson, M H Stein, E A Kastelein, J J Scott, R S Hunninghake, D B Campodonico, S Insull, W Escobar, I D Schrott, H G Stepanavage, M E Wu, M Tate, A C Melino, M R Mercuri, M Mitchel, Y B Producer: 20000317 In: Clinical cardiology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia. [electronic resource] by Davidson, M H Stein, E A Hunninghake, D B Ose, L Dujovne, C A Insull, W Bertolami, M Weiss, S R Kastelein, J J Scott, R S Campodónico, S Escobar, I D Schrott, H G Bays, H Stepanavage, M E Wu, M Tate, A C Melino, M R Kush, D Mercuri, M Mitchel, Y B Producer: 20010426 In: Nutrition, metabolism, and cardiovascular diseases : NMCD vol. 10 Availability: No items available. Save to lists Add to cart (remove)